Update On Insulin Management in Type 2 Diabetes

Insulin has been a cornerstone of therapy for diabetes mellitus since its discovery a century ago. The insulin analog formulations available today are vastly improved over the animal-derived insulins used for decades; pens and other devices used to administer insulin are also vastly improved. Further clinical benefits may be possible with insulins expected to be available in the near future, such as insulin degludec. There are many challenges with insulin therapy in the primary care setting, but strategies can be employed to address patient barriers, as well as to initiate and modify insulin therapy based upon patient response.

Insulin has been a cornerstone of therapy for diabetes mellitus since its discovery a century ago. The insulin analog formulations available today are vastly improved over the animal-derived insulins used for decades; pens and other devices used to administer insulin are also vastly improved. Further clinical benefits may be possible with insulins expected to be available in the near future, such as insulin degludec. There are many challenges with insulin therapy in the primary care setting, but strategies can be employed to address patient barriers, as well as to initiate and modify insulin therapy based upon patient response.

Insulin has been a cornerstone of therapy for diabetes mellitus since its discovery a century ago. The insulin analog formulations available today are vastly improved over the animal-derived insulins used for decades; pens and other devices used to administer insulin are also vastly improved. Further clinical benefits may be possible with insulins expected to be available in the near future, such as insulin degludec. There are many challenges with insulin therapy in the primary care setting, but strategies can be employed to address patient barriers, as well as to initiate and modify insulin therapy based upon patient response.